A featured poster session at the SGO 2018 Annual Meeting on Women’s Cancer detailed the results of a study comparing the efficacy and tolerability of PARP inhibitors as maintenance treatment in BRCA-mutated platinum-sensitive relapsed ovarian cancer.
Texas Oncology and Aetna partnered to provide a practice-based program that reduced costs while maintaining adherence to treatment pathways and patient satisfaction in Medicare patients.
Precision oncology strategies may improve overall survival for patients with refractory cancer while lowering the average per-week health care costs, resource utilization, and end-of-life costs.
Panelists shared their strategies of enhancing care coordination for patients in the transition toward value-based care planning.
The advantages of implementing technology into the daily operations of a community-based practice vary from finding inefficiencies in operational processes for identifying gaps to optimizing value-based care.
A session highlighted strategies for managing clinical trials for cancer and improving patient accrual in the community setting.
Younger patients who received certain chemotherapies for solid tumors or leukemia may not have T-cells capable of becoming effective CAR T-cells.
A recent literature review analyzed the alternative payment models used in the real world and how they have affected the quality of oncology care.
Widespread use of alternative payment models may improve the quality of breast and colorectal cancer screening programs.
A recent study investigated whether risk-standardized mortality rate is an effective predictor of long-term survival in hospitalized patients with heart failure.